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Aging occurs as a series of small steps, first causing cellular damage and then affecting tissues and organs. This is
also true in the brain. Frailty, a state of increased risk due to accelerated deficit accumulation, is robustly a risk factor
for cognitive impairment. Community-based autopsy studies show that frail individuals have brains that show
multiple deficits without necessarily demonstrating cognitive impairment. These facts cast a new light on the
growing number of risk factors for cognitive impairment, suggesting that, on a population basis, most health
deficits can be associated with late-life cognitive impairment. The systems mechanism by which things that are bad
for the body are likely to be bad for the brain can be understood like this: the burden of health deficits anywhere
indicates impaired ability to withstand or repair endogenous and environmental damage. This in turn makes
additional damage more likely. If true, this suggests that a life course approach to preventing cognitive impairment
is desirable. Furthermore, conducting studies in highly selected, younger, healthier individuals to provide ‘proof of
concept’ information is now common. This strategy might exclude the very circumstances that are required for disease
expression in the people in whom dementia chiefly occurs (that is, older adults who are often in poor health).Introduction
Until death intervenes, aging in humans is inevitable
and inexorable. The aging process has been conceptual-
ized as occurring in small increments as a result of a
preference for resources that serve reproduction over
those that serve repair. With time, such microscopic
damage accumulates, leading to clinically detectable defi-
cits, which themselves manifest as tissue, organ, and func-
tional impairment [1].
Longevity, contrary to initial predictions, has been
accelerating, in part because health care continues to
improve in treating disability and comorbidity [2]. How
this will play out is as yet unclear. Even given recent
revisions in whether late-life mortality plateaus occur
[3], there is concern that the burden of chronic disease
might increase, as people more often survive illnesses
that are now more disabling than fatal. Alternately,
although more diseases might accumulate, better manage-
ment could result in a lesser overall burden on health.
This in turn would result in more chronic illness, even if
individual diseases themselves were less burdensome. The* Correspondence: kenneth.rockwood@dal.ca
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creativecommons.org/publicdomain/zero/1.0/evidence to date favors the latter, in part because older
adults who are disabled are more likely to die than their
non-disabled age peers [2, 4]. Still, given how tightly age is
linked to dementia risk, the worry persists that increasing
late-life longevity, to the extent that it drives population
aging, will fuel a rising number, and proportion, of people
with dementia [5].
Although understanding health and aging requires
some nuance, the starting point is clear. At least since
Gompertz in the 19th century, we have recognized that
across the adult lifespan the risk of death increases expo-
nentially with age. One implication of this is that, al-
though single-system illness predominates in mortality
risk when people are younger, the acceleration in mor-
tality risk beginning partway through the sixth decade
reflects that many interacting factors are implicated in
causing death [6]. Equally clear, however, is that not
every one of the same age has the same risk of death at
that age. For some time, the term applied to the in-
creased risk of death at a given age, compared with their
age peers, has been frailty [7]. Likewise, people who
are fit have a lower risk of death than do others of
the same age.
Frailty is now well recognized as a risk factor for
dementia [8–10]. Even so, nuance is required here too.
In general, two views of frailty are widely recognized [11]
and they suggest different mechanistic understandings. ByAccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
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reflecting deficit accumulation (that is, of being more a
state than it is a phenotype or syndrome), which is a com-
peting (if still complementary) view.
Our goals here are, first, to critically evaluate the claim
that frailty is related to cognitive impairment and, second,
to suggest implications of this relationship for understand-
ing dementia prevention and treatment and for the design
and analysis of clinical trials.
Methods
A PubMed review was performed (and last updated 4
Nov. 2014) by using the key words ‘frail’, ‘frailty’, ‘frail
elderly’, ‘cognitive impairment’, ‘dementia’, and ‘Alzheimer’s
disease’ and limiting publication date to 1 Jan. 2000 up to
and including the above date. Initially, we identified 1145
articles, which then were screened initially by abstract and
where necessary by manuscript, resulting in 317 articles
that met our criteria. The vast majority of these articles
identified ‘frail’ as individuals at increased risk of adverse
outcome. Thirty-nine articles presented associations or
incident risks of between an operationalized frailty as-
sessment and cognitive impairment; two specifically
identified cognitive impairment as a risk factor for inci-
dent frailty [9, 12]. Where frailty was operationalized, the
majority used a variation of the phenotype definition [13].
Additional hand searches were performed, yielding 30
articles that were not found in the organized search, be-
cause they covered either frailty or cognitive impairment
(in isolation).
Frailty as a phenotype and frailty as deficit
accumulation
The phenotypic approach to frailty is widely used [13]. It
holds that frailty is best understood as a syndrome. Five
features are proposed: impaired grip strength, exhaustion,
slowed gait speed, weight loss, and reduction in activities.
An early report reckoned that the presence of frailty in-
creased the risk of dementia. This was of interest and has
motivated a great deal of work (in part to address the issue
of whether the frailty syndrome should be expanded to
include aspects of cognition and affect) [14].
Given that each of the items that make up the frailty
phenotype is recognized as a risk factor for dementia
[8, 15, 16], that they should also convey risk when com-
bined cannot be seen as surprising. In consequence, here
we will evaluate more the relationship between health
deficits broadly construed—as potentially including, but
not being restricted to, the five phenotypic features. That
is to say that we will focus on another common view of
frailty, which is that it is a state of increased risk; this risk
arises in relation to the number of health deficits that
people have and is mitigated by protective factors [17–19].
According to this formulation, the reason that as peopleage they are more likely to die and that people of the same
age have varying risks of death is that, in general, the risk
of death is related to the number of health deficits that
people accumulate. In short, the more health deficits that
an individual has, the more likely they are to die or
to experience other adverse health outcomes, includ-
ing worsening health status. Not everyone accumu-
lates deficits at the same rate, and it is the people who
have accumulated the most deficits who, at any age, are
more likely to die than their age peers. This then is the
basis of frailty [20].
The deficit accumulation approach yields several im-
portant features [21]. In cross-sectional evaluations at
least from age 50 (and, in some Western studies, across
the life course) in high-, middle-, and low-income coun-
tries around the world [21–24], health deficits accumulate
at approximately the same rate (about 3.5 % per year) and
are typically higher in women than in men. Consistent
across frailty indexes (FIs), there appears to be a fixed limit
to deficit accumulation. The deficit accumulation approach
operationalizes frailty as the proportion of things wrong
(that is, as the ratio of the number of health deficits present
in an individual to the number of health deficits that were
considered). For example, in a database that included 50
items that met the criteria to be considered health deficits,
a person in whom 10 such deficits were present would
have an FI of 10 out of 50, or 0.20. As it turns out, in both
community-dwelling and hospitalized patients (and in in-
tensive care unit series), the 99 % limit to frailty is 0.7. In
short, at least 99 % of people will have FIs of less than 0.7
[22, 23, 25]. That is because the closer an individual is to
an FI of 0.7, the greater is their risk of dying.
Health deficit accumulation begins as a consequence
of subcellular processes [1]. How subcellular damage
scales up to produce clinically detectable health deficits
is a matter of ongoing inquiry [26]. Of note, a key step
appears to be captured by subclinical events; for example,
even minor laboratory abnormalities can be detected in
otherwise well people, and their presence increases the
risk of adverse health outcomes [27].
Inevitably, the brain is not spared in the aging process.
Both cognitive impairment and dementia, in their various
forms, rise with age [28]. By this line of reasoning, it is no
coincidence that Alzheimer’s disease incidence is highest
in those who are at least 80 years old because these will be
the people with the greatest number of deficits otherwise.
Recent data suggest that deficit accumulation and cogni-
tive impairment are related, regardless of whether the defi-
cits are considered as traditional risk factors [10, 29, 30].
Aging: health deficits accumulate in the body and
brain
In the Rush Memory and Aging Project, older adults who
were frail demonstrated more Alzheimer’s pathology than
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was true not just in people with dementia but in the non-
demented patients as well [31]. In other words, physical
frailty in the body reflected the accumulation of neuro-
pathological lesions in the brain more than it did cognitive
function. Interestingly, there seemed to be no relationship
between frailty and microinfarcts or Lewy body findings in
this particular study. This result has been replicated in
data from the Religious Orders Study. More recently, pub-
lished neuropathology data have shown additional links
between cognitive impairment and frailty, suggesting com-
mon mechanisms [9, 32]. The full picture is still murky.
As highlighted in a recent review, longitudinal studies
have identified frailty to be a risk factor for non-
Alzheimer’s dementia as well as more general cognitive
impairment [8]. Note, however, that clinical dementia was
not present in a significant proportion of the patients who
met neuropathological criteria for Alzheimer disease; why
this is so remains unclear, although speculation casts
doubt on whether it is amyloid plaques or traditionally less
readily demonstrable amyloid protein forms that are
associated with neurotoxicity [33]. Abnormal amyloid
deposition appears in some pathways to be necessary
but not always sufficient and sometimes to be irrelevant.
In short, it might very well be that amyloid deposition is
more a risk factor than a cause. Furthermore, it might be
that combinations of not just clinical but neuropatho-
logical deficits are needed: for example, work from the
Honolulu-Asia Aging Study showed that multiple patholo-
gies were associated with dementia, including in people
with Alzheimer’s disease [34].
In short, it appears that as a range of health deficits
accumulate, more disease entities will appear. This is not
restricted to dementia but rather is highlighted in recent
publications which show that so-called ‘non-traditional
risk factors’ increase the risk for other late-life health
problems, including osteoporosis [35] and cardiovascular
disease [36]. That many outcomes are multiply deter-
mined is the challenge of studying the diseases of aging
[4]. A sharp focus on disease mechanisms, studied in
their purest form, has undergirded considerable scien-
tific advances, and so it is not surprising that this is the
dominant approach in Alzheimer disease. This emphasis
on studying ‘pure’ Alzheimer’s disease extends into clin-
ical trials, which commonly focus on patients who have
little else wrong. If multiple deficits are required for
disease expression in late life, how wise a strategy this is
remains unclear. Although Alzheimer’s disease can tra-
gically be seen in young people and in older adults who
are otherwise fit, the list of individual risk factors that
are associated with it is long, including ischemic car-
diovascular disease, cardiac arrhythmias (notably, atrial
fibrillation), congestive heart failure, atherosclerosis,
hypertension, chronic kidney disease (CKD), insulininsensitivity, sleep disorders, chronic inflammation, im-
munosenescence, and obesity [8, 37].
Multifactorial mechanisms of cognitive impairment
As noted in a recent Nature commentary, ‘[t]he prob-
lems of old age come as a package’ [4].
Many of the comorbidities investigated as risk factors
for dementia themselves are associated with additional
risks for cognitive impairment. For instance, CKD, most
commonly caused by diabetes mellitus and hypertension
in the developed world, has been shown to be a risk fac-
tor for cognitive impairment [38]. Unsurprisingly, CKD
is most prevalent at older ages. Common mechanisms
have been considered: both the brain and kidneys are
uniquely profused and sensitive to microvascular injury,
and so perhaps cognitive impairment in people with
CKD represents the same process in different organ sys-
tems. In our view, however, this cannot be the complete
story of their coincidence. CKD exacerbates hyperten-
sion, limits medication choices in patients with diabetes,
and contributes to a range of metabolic abnormalities
and complications such as anemia, acidosis, hyperpho-
sphatemia, hypoalbuminemia, and hyperparathyroidism.
These are themselves related to cognitive impairment
and not solely via microvascular mechanisms. For ex-
ample, anemia has been shown to increase risk for
Alzheimer’s disease [39], and even mild anemia has
been associated with poorer performance on Trails B
testing [39]. Likewise, changes that synergistically worsen
renal sodium and water physiology are also common in
older adults, especially those who are frail. Hyponatremia
is common in older adults and has been proposed to
reflect the combined effects of a weaker central thirst
response, abnormal antidiuretic hormone levels, and
decreased ability of the kidneys to concentrate urine [40].
Sodium disturbances have been a potent stimulus for
delirium [41, 42]. The many interacting mechanisms by
which cognitive impairment can arise in the face of accu-
mulating health deficits are not limited to CKD. Cognitive
impairment is linked to congestive heart failure [43], again
with many factors linking them beyond vascular risk
factors. Decreased cerebral perfusion, cerebral reactivity
[44], oxidative stress, inflammation, microemboli, and
neurohumoral affects are each shared by the two condi-
tions. Similarly, many other factors can be implicated in
late life dementia, reflecting the variable pathways by
which it can arise [10].
As with the individual items that make up the frailty
phenotype, combining other known risk factors for cog-
nitive impairment (here, vascular risk factors) improves
prediction of dementia risk [45]. Strikingly, however,
even health deficits not routinely identified as risk fac-
tors for dementia or cognitive impairment have been
shown to be factors predicting dementia and Alzheimer’s
Searle and Rockwood Alzheimer's Research & Therapy  (2015) 7:54 Page 4 of 6disease [30]. This suggests that there are multiple mech-
anisms for developing dementia beyond vascular risk
factors and that a systems approach might be useful in
understanding the link between risk factors and late-life
dementia.
Deficit accumulation and failing repair processes
One example of a systems approach to understanding
how multiple risk factors might combine to be associ-
ated with late-life dementia is the application of queuing
theory to deficit accumulation. A broadly applicable dis-
cipline in applied mathematics, queuing theory describes
how a queue operates [46], how it lengthens or shortens,
and so provides an analogy with deficit accumulation.
The length of a queue is a function of the rate at which
people arrive at the queue and the amount of time it
takes to process them. Likewise, the number of deficits
that a person accumulates (that is, the magnitude of
their FI) is the product of the rate at which damage
arises and the rate at which it is repaired (or removed).
With this model, the assumption is that, in the near
term, the rate of damage arising from both the external
and the internal environment is constant, so that change
in the FI (usually increasing) chiefly reflects change (usu-
ally slowing) in the rate of repair/removal of damage. It
is important to note that damage makes further damage
more likely, in that as recovery time increases, there is
less time to repair deficits before new damage arises. In
consequence, health deficits accumulate, exponentially
so, especially as repair processes themselves become
damaged.
This has been recently proposed for dementia specific-
ally [10]. It follows that improving both the environment
(that is, the rate at which damage arises) as well as the
medical management of health issues (for example, co-
morbidity management, improved social structure, and
the like) should help both cognitive impairment and
frailty by improving repair capability and shortening re-
covery times. Understanding dementia risk in relation to
“impaired repair function” is to invoke what is purposely
a broad construct. At a very general level, a deficit arises
whenever damage goes unremoved or unrepaired [46].
In consequence, if the nature of damage varies—if the
range of risks that are associated with dementia is
wide—then one way of understanding how these diverse
exposures result in dementia has less to do with the dam-
age itself, than it does with either an aberrant repair
process, or simply a slow one. On average, repair pro-
cesses slow with time—recovery time increases with age
[46]. Considering how commonly it occurs in late life,
what gives rise to dementia may be less the nature of the
damage than a more widespread increase in recovery time.
Brain deficits accumulate due to many mechanisms
[26, 46, 47]. Consider that to date, the single mostimportant intervention for both frailty and cognition ap-
pears to be exercise [48]. Exercise is an example of how
a single intervention can have multiple mechanisms for
mitigating the development of cognitive impairment.
These include direct effects on brain function and struc-
ture by neurogenesis, angiogenesis, synaptogenesis, hip-
pocampal volume, attenuated frontal loss of grey and
white matter, and increased connectivity on the large
scale brain circuitry [49]. This appears to be in addition
to its indirect effects on cognitive functioning via treat-
ment of cardiovascular risk factors, depression, anxiety,
chronic stress, and potentially diet and sleep [48]. In
short, just because a disease might arise from many
mechanisms, mechanisms that could even be pragmatic-
ally unknowable for given individuals, interventions can
still be possible, if such interventions are broadly based.
Likewise, there is evidence that medical management of
a range of comorbidities can improve cognitive out-
comes even if the degree of improvement in relation to
single maneuvers varies [49–51].
Summary
Many comorbid physical illnesses are noncontroversially
associated with changes in the brain. A large number of
illnesses are associated with the classic lesions of Alzhei-
mer’s disease. Intriguingly, in the Honolulu-Asia Aging
Study and the Rush Memory and Aging Project, it has
been demonstrated that the relationship between brain
pathology and cognitive impairment is best understood
in relation to the accumulation of lesions—atrophy, pla-
ques, tangles, Lewy bodies, and microinfarction [34]—but
in the latter study, this relation is not associated with any
single lesion type.
Likewise, aging and cognitive impairment are closely
related. This appears not to be by coincidence. With
aging, cellular and molecular damage accumulates,
ultimately giving rise to deficits that are visible by la-
boratory measures and as macroscopically detectable
variables. These macroscopically detectable health defi-
cits can have the status of disease. Common diseases,
such as cardiovascular risk factors, now are noncon-
troversially associated with all causes of late-life cog-
nitive impairment, including Alzheimer’s disease.
Recent work has extended this approach to under-
standing late-life cognitive impairment to a large variety
of items that traditionally have not been associated with
dementia.
There might be particular merit, especially in diseases
expressed chiefly in late life, of considering the malign
influence of interacting factors, and not just single
mechanisms, on three grounds. First, it appears to be
generalizable, having been demonstrated further in the
SHARE (Survey of Health, Ageing and Retirement in
Europe) database [29]. Second, it likewise seems to
Note: This article is part of a series on The impact of acute and
chronic medical disorders on accelerated cognitive decline, edited
by Carol Brayne and Daniel Davis. Other articles in this series can
be found at http://alres.com/series/medicaldisorders
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to other disorders, such as coronary heart disease events
[36] and osteoporotic fractures [35]. Third, it allows an
understanding of the proliferation of a very large num-
ber of putative risk factors for dementia—something that
now risks exhaustion in not just the public but also the
scientific community.
Understanding that frailty and cognitive impairment
are linked has implications for how we test drugs for de-
mentia. At present, many proof-of-concept studies with
disease-modifying drugs are focusing further upstream:
on healthier people who are typically younger and have
few things wrong and even few symptoms. Perhaps,
however, the impairment represented by deficit accumu-
lation (a collective series of events that impair repair
capacity generally) is what is needed to allow the earliest
lesions seen in ‘Alzheimer’s’ to express their toxicity and
so give rise to disease. If this is true, then only treatment
effects will be found on those who are impaired. This in-
triguing observation is motivating further inquiries by
our group.Conclusions
Frailty and cognition are related to each other and to
aging (Box 1). The growing list of risk factors for demen-
tia might simply reflect that both health deficit accumu-
lation (frailty) and cognitive impairment are common in
late life. Clinical trials in dementia should consider not
excluding frail older adults, as frailty appears to drive
disease expression and might be needed for the classic
neuropathology of dementia to express its deleterious
effects.Box 1 Highlighting points
 Frailty has been linked to cognitive impairment.
 Shared mechanisms might include both shared subcellular
pathophysiology (for example, oxidative stress and protein
misfolding) and systems mechanisms—as well as impaired
repair (for example, failures in chaperone proteins,
autophagy)—give rise to deficits at this level.
 These mechanisms are not unique to dementing illnesses
and, especially in their multiplicity, implicate what is seen
with aging.
 If the dementias, which occur chiefly in late life, exist
because of multiple deficits, reflecting multiple mechanisms,
this calls into question the notion of ‘proof of concept’ for
Alzheimer’s disease treatment that focuses on younger
patients with few health problems.Abbreviations
CKD: chronic kidney disease; FI: frailty index.
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